[Federal Register Volume 61, Number 221 (Thursday, November 14, 1996)]
[Notices]
[Page 58417]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-29147]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration


Advisory Committees; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces the renewal 
of certain FDA advisory committees by the Commissioner of Food and 
Drugs (the Commissioner). The Commissioner has determined that it is in 
the public interest to renew the charters of the committees listed 
below for an additional 2 years beyond charter expiration date. The new 
charters will be in effect until the dates of expiration listed below. 
This notice is issued under the Federal Advisory Committee Act of 
October 6, 1972 (Pub. L. 92-463 (5 U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates 
indicated below unless the Commissioner formally determines that 
renewal is in the public interest.

                                                                        
------------------------------------------------------------------------
          Name of committee                   Date of expiration        
------------------------------------------------------------------------
Pulmonary-Allergy Drugs Advisory      May 30, 1998.                     
 Committee                                                              
Drug Abuse Advisory Committee         May 31, 1998.                     
Science Advisory Board to the         June 2, 1998.                     
 National Center for Toxicological                                      
 Research                                                               
Peripheral and Central Nervous        June 4, 1998.                     
 System Drugs Advisory Committee                                        
Psychopharmacologic Drugs Advisory    June 4, 1998.                     
 Committee                                                              
Science Board to the Food and Drug    June 26, 1998.                    
 Administration                                                         
Transmissible Spongiform              June 9, 1998.                     
 Encephalopathies Advisory Committee                                    
 (formerly Ad Hoc Advisory Committee                                    
 on Creutzfeldt-Jakob Disease)                                          
Allergenic Products Advisory          July 9, 1998.                     
 Committee                                                              
Cardiovascular and Renal Drugs        August 27, 1998.                  
 Advisory Committee                                                     
Endocrinologic and Metabolic Drugs    August 27, 1998.                  
 Advisory Committee                                                     
Oncologic Drugs Advisory Committee    September 1, 1998.                
Anti-Infective Drugs Advisory         October 7, 1998.                  
 Committee                                                              
Dermatologic and Ophthalmic Drugs     October 7, 1998.                  
 Advisory Committee                                                     
Biological Response Modifiers         October 28, 1998.                 
 Advisory Committee                                                     
------------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT:  Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4820.

    Dated: November 6, 1996.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 96-29147 Filed 11-13-96; 8:45 am]
BILLING CODE 4160-01-F